Skip to main
AHR
AHR logo

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 67%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT Inc. has demonstrated robust rental rate growth of 4.1% year-over-year, alongside exceptional same-store NOI growth of 25.3% in the Senior Housing Operating (SHOP) segment and 21.7% in the Integrated Senior Health Campus (ISHC) segment. The operator benefits from favorable industry trends and has achieved the highest growth rate in Funds From Operations (FFO) within the Healthcare REIT sector, reflecting a strong operational performance. Furthermore, with improved cost of capital and significant cash NOI growth, the company is well-positioned for continued organic growth, particularly within its Trilogy and SHOP segments, which are projected to deliver impressive compound annual growth rates over the next two years.

Bears say

American Healthcare REIT Inc. has seen improvements in leverage with net debt to GAV decreasing from 42.2% to 31.1% year-over-year, while net debt to annualized EBITDA has improved from 5.1x to 3.5x. However, the potential for economic headwinds and changes in regulatory conditions in certain geographies poses risks to tenant operating performance, which may hinder the company's ability to meet earnings expectations. Additionally, anticipated lower Medicaid rates for their tenants could further impact earnings, suggesting that while there are growth prospects, the overall financial stability of the company may be under threat.

AHR has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 67% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 12 analysts, AHR has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $50.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $50.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.